Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 1 minute read General business news Macfarlane boosts protective packaging portfolio with B&D acquisition Macfarlane takes a significant stride in its growth trajectory with the announcement of its latest acquisition, B&D 2010… byPallavi MadhirajuOctober 2, 2023